Homozygous mutations in FANCD1/BRCA2 are associated with FA disease, while inherited heterozygous mutations in FANCD1/BRCA2 are associated with an increased risk of developing breast and ovarian cancers. Here, BRCA2 is linked to ovarian carcinoma.